Aera Therapeutics is a biopharmaceutical company that develops transformative genetic medicines for modalities and therapeutic areas. Its protein nanoparticle (PNP) delivery platform leverages the discovery of endogenous human proteins that can self-assemble to form capsid-like structures. The company's genetic medicine payloads include siRNA, mRNA, antisense oligos (ASOs), DNA, and gene editing systems.